New advances toward safely targeting immune cells to pediatric brain tumors
- OPACC
- May 1, 2020
- 1 min read
Stanford scientists have taken important steps toward figuring out how to use immune therapy for a group of severe pediatric brain tumors known as atypical teratoid/rhabdoid tumors.
Yorumlar